eLifeNeurosciencePeer-reviewed journal article
Prefoldin 5 is a microtubule-associated protein that suppresses Tau-aggregation and neurotoxicity
Anjali BishtiD, Srikanth PippadpallyiD, Snehasis Majumder, Athulya T Gopi, Abhijit DasiD, Chandan SahiiD, Mani RamaswamiiD, Vimlesh KumariD
Abstract
Tauopathies represent a major class of neurodegenerative disorders associated with intracellular aggregates of the microtubule-associated protein Tau. To identify molecular modulators of Tau toxicity, we used a genetic screen to identify protein chaperones whose RNAi-mediated knockdown could modulate hTauV337M-induced eye-ommatidial degeneration in Drosophila. This screen identified the Prefoldins Pfdn5 and Pfdn6 as strong modifiers of hTauV337M cytotoxicity. Consistent with the known function of Pfdn as a cotranslational chaperone for tubulin, Pfdn5 mutants showed substantially reduced levels of tubulin monomer. However, additional microtubule-related functions were indicated by the robust unexpected association of Pfdn5 with axonal microtubules in vivo, as well as binding with stabilized microtubules in biochemical assays. Loss of Pfdn5 resulted in neuromuscular junctions (NMJ) defects similar to those previously described in hTau-expressing flies: namely, increased supernumerary boutons and fewer microtubule loops within mature presynaptic boutons. Significantly, synaptic phenotypes caused by hTauV337M overexpression were also strongly enhanced in a Pfdn5 mutant background. Consistent with a role in modulating Tau toxicity, not only did loss of Pfdn5 result in increased accumulations of Tau-aggregates in hTauV337M expressing neurons, but also neuronal overexpression of Prefoldin strikingly ameliorated age-dependent neurodegeneration and memory deficits induced by pathological hTau. Together, these and other observations described herein: (a) provide new insight into Prefoldin-microtubule interactions; (b) point to essential posttranslational roles for Pfdn5 in controlling Tau-toxicity in vivo; and (c) demonstrate that Pfdn5 overexpression is sufficient to restrict Tau-induced neurodegeneration.
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced Microtubule Polyglutamylation Perturbs Neuronal Function and Accelerates Tau-Induced Neurodegeneration
Shreyangi Chakraborty, Silvia Poggini, … Maria M. Magiera·bioRxiv·Sep 25, 2026
- Injury-induced tau pathology promotes aggressive behavior in Drosophila without neurodegeneration.
Roilea Maxson, Christine J. Smoyer, … Kassandra M Ori-McKenney·Proceedings of the National Academy of SciencesPeer-reviewed·Jun 30, 2026
- Dominant α-tubulin mutations rescue tauopathy neurodegenerative phenotypes in C. elegans
Sarah J. Benbow, Aleen D. Saxton, … Brian C. Kraemer·bioRxiv·Mar 20, 2026
- A conserved serotonin receptor pathway is a druggable modifier of Tau pathology, neural circuit formation and neurodegeneration
Mariana I Tsap, Valeriya Navrotskaya, … Halyna R. Shcherbata·bioRxiv·Aug 27, 2026
- Aggregation promoting sequences rather than phosphorylation are essential for Tau-mediated toxicity in Drosophila
Amber S. Cooper, Bradley Richardson, … Amritpal K. Mudher·bioRxiv·Dec 22, 2024
- String/Cdc25 phosphatase is a suppressor of Tau-associated neurodegeneration
Andreia C. Oliveira, Madalena Santos, … Carla S. Lopes·Disease Models & MechanismsPeer-reviewed·Jan 1, 2023